PRS11 COST-EFFECTIVENESS OF INCREASING MAINTENANCE DOSES WITH BUDESONIDE/FORMOTEROL MAINTENANCE + RELIEVER THERAPY
نویسندگان
چکیده
منابع مشابه
Single maintenance and reliever therapy.
Single maintenance and reliever therapy The paper by Chapman et al reviewing single maintenance and reliever therapy (SMART) in asthma is important in highlighting some of the inadequacies of existing research evaluating this treatment method. The authors also claim that SMART fails to achieve adequate asthma control as measured by GINA criteria and provide a table detailing seven studies and a...
متن کاملUpdated Medication Costs From A Real-Life Cost-Effectiveness Evaluation Of Budesonide/Formoterol Maintenance And Reliever Therapy In Asthma Maintenance And Reliever Therapy In Asthma.
per patient and year compared to SEK 4 710.9 in 2006 per patient and year. The budesonide/formoterol MART arm was also less costly compared to the FDC arm (SEK 4 163.2 per patient and year) and to the FAC arm (SEK 7 498.5 per patient and year) (Table 2). Similar results were found in Denmark where medication costs for the budesonide/formoterol MART arm (DuoResp® Spiromax®) were less in 2015 DKK...
متن کاملCost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy
Study sample Of the 4,399 patients initially identified, 3,335 were eligible and were included in the final study sample. There were 1,123 patients (43% men) in the fixed-dose SAL-FLU group, 1,105 patients (41% men) in the BUD-FORM group and 1,107 patients (43% men) in the SMART group. The mean age of the patients was 38 years (age range: 12 to 83) in the fixed-dose SAL-FLU group, 38 years (age...
متن کاملCost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
BACKGROUND Budesonide/formoterol (Symbicort) Maintenance and Reliever Therapy (SMART) is an effective asthma-management approach that treats symptoms with rapid increases in budesonide/formoterol. The cost-effectiveness of SMART vs higher fixed-dose budesonide/formoterol or salmeterol/fluticasone is unknown. METHODS This 6-month, double-blind study randomized patients with asthma uncontrolled...
متن کاملA real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
OBJECTIVE To evaluate direct asthma-related costs in Swedish primary care in a real-life setting. DESIGN 12-month open-label study. SETTING Swedish primary care in a real-life setting. PARTICIPANTS 1776 patients with persistent asthma. INTERVENTIONS Patients with persistent asthma were randomised to one of three treatments: a free adjustable combination of budesonide (100-400 microg/inh...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2008
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)66508-4